PDGFR Inhibitor Crenolanib in Children/Young Adults With Diffuse Intrinsic Pontine Glioma or Recurrent High-Grade Glioma

NCT01393912 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

55

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Intrinsic Pontine Glioma
Progressive or Refractory High-Grade Glioma

Interventions

DRUG: Crenolanib

Sponsor

St. Jude Children's Research Hospital

Collaborators

[object Object]
[object Object]